References

Cassileth BR, Keefe FJ. Integrative and Behavioral Approaches to the Treatment of Cancer-Related Neuropathic Pain. Oncologist. 2010;15(2):19-23.

Chambers WA. Nerve blocks in palliative care. Br J Anaesth. 2008;101:95-100.

Davis MP. Recent development in therapeutics for breakthrough pain. Expert Rev Neurother. 2010;10(5):757-73.

Fairchild A, Chow E. Role of radiation therapy and radiopharmaceuticals in bone metastases. Curr Opin Support Palliat Care. 2007;1:169-73.

Foley KM, Abernathy A. Management of Cancer Pain. In DeVita VT Jr, Lawrence TS, Rosenberge SA, eds. Cancer: Principles and Practice of Oncology, 8th Ed. 2008, Philadelphia, Lippincott Williams and Wilkins. pp 2757-2790.

Kedlaya D, Reynolds L, Waldman S. Epidural and intrathecal analgesia for cancer pain. Best Pract Res Clin Anaesthesiol. 2002;16:651-65.

Kroenke K, Theobald D, Wu J, et al. The association of depression and pain with health-related quality of life, disability, and health care use in cancer patients. J Pain Symptom Manage. 2010;40(3):327-41.

National Cancer Institute. Pain Control: Support for People with Cancer. Accessed at www.cancer.gov/cancertopics/paincontrol/page1 on September 20, 2010.

National Comprehensive Cancer Network Practice Guidelines in Oncology, V.1.2010. Adult Cancer Pain. Accessed at http://www.nccn.org/professionals/physician_gls/PDF/pain.pdf on September 20, 2010.

US FDA Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Accessed at www.accessdata.fda.gov/scripts/cder/ob/default.cfm on September 21, 2010.

Wiffen PJ, McQuay HJ. Oral morphine for cancer pain. Cochrane Database Syst Rev. 2007; CD003868.